Related Experiment Video
Updated: Feb 8, 2026
07:33
A Mouse Model of Intestinal Partial Obstruction
Published on: March 5, 2018
22.6K
[Chronic intestinal pseudo-obstruction in adults].
A Egal1, P Jouët1, D Lamarque1
1Service d'hépato-gastro-entérologie, hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, 92104 Boulogne-Billancourt, France.
La Revue De Medecine Interne
|June 26, 2018
Summary
Chronic intestinal pseudo-obstruction, a rare motility disorder, presents diagnostic and therapeutic challenges. Further understanding of its pathophysiology is crucial for improving patient care and treatment outcomes.
Area of Science:
- Gastroenterology and Internal Medicine
- Rare Diseases
- Gastrointestinal Motility Disorders
Background:
- Chronic intestinal pseudo-obstruction (CIPO) is a rare condition characterized by impaired gastrointestinal motility.
- Symptoms are often non-specific and vary widely, complicating diagnosis and clinical management.
- Current treatments are largely symptomatic, focusing on prokinetics and nutritional support, with surgery reserved for severe cases.
Purpose of the Study:
- To review the current understanding of chronic intestinal pseudo-obstruction.
- To highlight diagnostic challenges and therapeutic approaches.
- To emphasize the need for deeper insights into the disease's underlying mechanisms.
Main Methods:
- Review of existing literature on chronic intestinal pseudo-obstruction.
- Analysis of diagnostic criteria and therapeutic strategies.
- Discussion of etiological factors and treatment outcomes.
Main Results:
- Diagnosis relies on a combination of clinical evaluation, imaging, and specialized tests, often requiring expert centers.
- Treatment efficacy is variable, with symptomatic management and nutritional support being primary interventions.
- Etiological treatment is only possible when the underlying cause is identified, yielding inconsistent results.
Conclusions:
- Chronic intestinal pseudo-obstruction remains poorly understood despite advances in diagnosis and treatment.
- A comprehensive understanding of the physiopathological mechanisms is essential for advancing clinical practice.
- Further research is needed to improve diagnostic accuracy and therapeutic effectiveness for CIPO patients.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.2K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.8K